Alliancebernstein L.P. Sanofi Transaction History

Alliancebernstein L.P.

$280 Billion
Q4 2024

A detailed history of Alliancebernstein L.P. transactions in Sanofi stock. As of the latest transaction made, Alliancebernstein L.P. holds 48,929 shares of SNY stock, worth $2.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,929

Previous 49,533 1.22%

Holding current value

$2.67 Million

Previous $2.86 Million 17.37%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$45.89 - $57.31 $27,717 - $34,615	-604 Reduced 1.22%	48,929 $2.36 Million
Q3 2024 Nov 14, 2024	SELL	$48.54 - $58.53 $23,541 - $28,387	-485 Reduced 0.97%	49,533 $2.86 Million
Q2 2024 Aug 14, 2024	SELL	$45.39 - $50.36 $226,632 - $251,447	-4,993 Reduced 9.08%	50,018 $2.43 Million
Q1 2024 May 14, 2024	SELL	$45.75 - $52.48 $73,245 - $84,020	-1,601 Reduced 2.83%	55,011 $2.67 Million
Q4 2023 Feb 14, 2024	SELL	$43.13 - $54.79 $87,942 - $111,716	-2,039 Reduced 3.48%	56,612 $2.82 Million
Q3 2023 Nov 14, 2023	SELL	$50.95 - $55.2 $161,868 - $175,370	-3,177 Reduced 5.14%	58,651 $3.15 Million
Q2 2023 Aug 15, 2023	SELL	$50.45 - $57.18 $4,691 - $5,317	-93 Reduced 0.15%	61,828 $3.33 Million
Q1 2023 May 15, 2023	BUY	$45.86 - $54.45 $98,920 - $117,448	2,157 Added 3.61%	61,921 $3.37 Million
Q4 2022 Feb 14, 2023	SELL	$38.86 - $48.55 $8.13 Million - $10.2 Million	-209,106 Reduced 77.77%	59,764 $2.89 Million
Q3 2022 Nov 15, 2022	SELL	$37.22 - $100.5 $898,453 - $2.43 Million	-24,139 Reduced 8.24%	268,870 $10.2 Million
Q2 2022 Aug 15, 2022	BUY	$48.99 - $57.46 $4.77 Million - $5.6 Million	97,455 Added 49.84%	293,009 $14.7 Million
Q1 2022 May 13, 2022	SELL	$48.48 - $53.65 $39,414 - $43,617	-813 Reduced 0.41%	195,554 $10 Million
Q4 2021 Feb 14, 2022	BUY	$47.07 - $52.35 $2.76 Million - $3.07 Million	58,681 Added 42.62%	196,367 $9.84 Million
Q3 2021 Nov 10, 2021	BUY	$47.89 - $53.12 $1.24 Million - $1.38 Million	25,982 Added 23.26%	137,686 $6.64 Million
Q2 2021 Jul 30, 2021	BUY	$49.36 - $54.25 $2.93 Million - $3.22 Million	59,424 Added 113.66%	111,704 $5.88 Million
Q1 2021 May 06, 2021	SELL	$45.46 - $50.51 $275,760 - $306,393	-6,066 Reduced 10.4%	52,280 $2.59 Million
Q4 2020 Feb 08, 2021	SELL	$45.3 - $51.62 $23,691 - $26,997	-523 Reduced 0.89%	58,346 $2.84 Million
Q3 2020 Nov 12, 2020	BUY	$49.47 - $53.77 $200,304 - $217,714	4,049 Added 7.39%	58,869 $2.95 Million
Q2 2020 Aug 13, 2020	BUY	$42.91 - $52.5 $116,500 - $142,537	2,715 Added 5.21%	54,820 $2.8 Million
Q1 2020 May 14, 2020	SELL	$38.02 - $51.66 $9,961 - $13,534	-262 Reduced 0.5%	52,105 $2.28 Million
Q4 2019 Feb 18, 2020	SELL	$44.25 - $50.86 $6.78 Million - $7.79 Million	-153,252 Reduced 74.53%	52,367 $2.63 Million
Q3 2019 Nov 14, 2019	BUY	$40.34 - $46.64 $6.03 Million - $6.97 Million	149,486 Added 266.31%	205,619 $9.53 Million
Q2 2019 Aug 14, 2019	SELL	$40.43 - $44.3 $4.3 Million - $4.71 Million	-106,376 Reduced 65.46%	56,133 $2.43 Million
Q1 2019 May 14, 2019	BUY	$40.83 - $45.43 $1.22 Million - $1.36 Million	29,866 Added 22.52%	162,509 $7.2 Million
Q4 2018 Feb 13, 2019	SELL	$41.48 - $45.59 $7.19 Million - $7.91 Million	-173,447 Reduced 56.67%	132,643 $5.76 Million
Q3 2018 Nov 08, 2018	BUY	$40.0 - $44.84 $10.5 Million - $11.8 Million	263,445 Added 617.76%	306,090 $13.7 Million
Q2 2018 Aug 13, 2018	SELL	$37.63 - $41.22 $5.67 Million - $6.22 Million	-150,806 Reduced 77.96%	42,645 $1.71 Million
Q1 2018 May 14, 2018	BUY	$38.98 - $45.76 $6.6 Million - $7.75 Million	169,287 Added 700.58%	193,451 $7.75 Million
Q4 2017 Feb 13, 2018	BUY	$42.86 - $50.61 $26,101 - $30,821	609 Added 2.59%	24,164 $1.04 Million
Q3 2017 Nov 13, 2017	BUY	$47.04 - $50.34 $1.11 Million - $1.19 Million	23,555	23,555 $1.17 Million

Others Institutions Holding SNY

# of Institutions

805

Shares Held

272M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $137B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Sanofi Transaction History